Diametric Capital, LP - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 39 filers reported holding OCUPHIRE PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Diametric Capital, LP ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$187,797
+53.4%
56,059
+98.7%
0.08%
+43.6%
Q2 2023$122,444
-41.3%
28,213
-49.3%
0.06%
-45.0%
Q1 2023$208,680
+150.5%
55,648
+135.8%
0.10%
+150.0%
Q4 2022$83,301
+70.0%
23,598
-3.9%
0.04%
+60.0%
Q3 2022$49,000
-25.8%
24,548
-28.5%
0.02%
-49.0%
Q2 2022$66,000
-60.2%
34,356
-33.3%
0.05%
-46.7%
Q1 2022$166,000
-50.3%
51,531
-42.4%
0.09%
-64.1%
Q4 2021$334,00089,4420.26%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 340,526$1,276,9762.16%
Knoll Capital Management, LLC 100,000$375,0000.58%
RICE HALL JAMES & ASSOCIATES, LLC 809,117$3,034,1890.17%
Diametric Capital, LP 55,648$208,6800.10%
MAI Capital Management 494,690$1,855,0880.03%
TRUST CO OF TOLEDO NA /OH/ 26,000$97,5000.02%
Bedel Financial Consulting, Inc. 15,000$56,2500.01%
Legato Capital Management LLC 16,456$61,7100.01%
OCCUDO QUANTITATIVE STRATEGIES LP 19,623$73,5860.01%
Cornerstone Capital, Inc. 16,357$61,3390.01%
View complete list of OCUPHIRE PHARMA INC shareholders